drug prices

New Drug Report Confirms Drug Prices On Unsustainable Path

Reaction from National Coalition on Health Care President and CEO John Rother on key findings from the “Express Scripts 2014 Drug Trend Report.”

Read more

Doctors group joins fight against ‘skyrocketing’ drug prices

A national group of more than 140,000 physicians on Tuesday joined a coalition dedicated to reversing the growing trend of high-cost specialty drugs, which are being blamed for straining the finances of patients, insurance plans and public health coverage programs.

Read more

Developing a Drug Costs $2.6 Billion, but not Everyone Believes This

The cost to develop a new drug and win FDA marketing approval is now pegged at nearly $2.6 billion, according to a new report from the Tufts Center for the Study of Drug Development.

Read more

[MarketWatch] Sovaldi pricing raises debate over drug costs

With the California-based drug manufacturer Gilead Sciences planning to roll out another hepatitis C medication, academics said Wednesday that policy changes are needed in the costly drug market so the interests of patients, health insurers and pharmaceutical companies align.

Read more